Cancer, oxidative stress, and metastasis

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 81, Issue 1, 2016, Pages 163-175

  Gill, Jennifer G ^a   Piskounova, Elena ^a   Morrison, Sean J ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; PROOXIDANT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; DIET SUPPLEMENTATION; GENE MUTATION; HIGH RISK PATIENT; HUMAN; MALIGNANT NEOPLASM; METASTASIS; MITOCHONDRION; MOLECULAR BIOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 85021042620     PISSN: 00917451     EISSN: 19434456     Source Type: Book Series    
DOI: 10.1101/sqb.2016.81.030791     Document Type: Article

References (172)

1. Abbas K, Breton J, Planson AG, Bouton C, Bignon J, Seguin C, Riquier S, Toledano MB, Drapier JC. 2011. Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages. Free Radic Biol Med 51: 107-114
2. Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, et al. 2011. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334: 1278-1283
3. ATBC. 1994. The effect of vitamin E and b carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. N Engl J Med 330: 1029-1035
4. Azzam EI, Jay-Gerin JP, Pain D. 2012. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett 327: 48-60
5. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. 1997. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221
6. Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK, Rosen EM. 2004. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 64: 7893-7909
7. Bensaad K, Tsuruta A, SelakMA, VidalMN,NakanoK, Bartrons R, Gottlieb E, Vousden KH. 2006. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120
8. Bhandary B, Marahatta A, Kim HR, Chae HJ. 2012. An involvement of oxidative stress in endoplasmic reticulum stress and its associated diseases. Int J Mol Sci 14: 434-456
9. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. 2007. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 297: 842-857
10. Blot WJ, Li JY, Taylor PR, GuoW, Dawsey S,Wang GQ, Yang CS, Zheng SF, Gail M, Li GY, et al. 1993. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85: 1483-1492
11. Boada J, Roig T, Perez X, Gamez A, Bartrons R, Cascante M, Bermudez J. 2000. Cells overexpressing fructose-2,6-bisphosphatase showed enhanced pentose phosphate pathway flux and resistance to oxidative stress. FEBS Lett 480: 261-264
12. Cameron MD, Schmidt EE, Kerkvliet N, Nadkarni KV, Morris VL, Groom AC, Chambers AF, MacDonald IC. 2000. Temporal progression of metastasis in lung: Cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60: 2541-2546
13. Cat B, Stuhlmann D, Steinbrenner H, Alili L, Holtkotter O, Sies H, Brenneisen P. 2006. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species. J Cell Sci 119: 2727-2738
14. Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT. 2000. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1α during hypoxia: A mechanism of O2 sensing. J Biol Chem 275: 25130-25138
15. Chen EI, Hewel J, Krueger JS, Tiraby C, Weber MR, Kralli A, Becker K, Yates JR III, Felding-Habermann B. 2007. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res 67: 1472-1486
16. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA. 1992. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G!T and A!C substitutions. J Biol Chem 267: 166-172
17. Chio II, Jafarnejad SM, Ponz-Sarvise M, Park Y, Rivera K, Palm W, Wilson J, Sangar V, Hao Y, Ohlund D, et al. 2016. NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer. Cell 166: 963-976
18. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, et al. 1996. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276: 1957-1963
19. Debnath J, Brugge JS. 2005. Modelling glandular epithelial cancers in three-dimensional cultures. Nat Rev Cancer 5: 675-688
20. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. 2002. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111: 29-40
21. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A,Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, et al. 2011. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475: 106-109
22. DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, WuD, Tang H, Xie Y, Asara JM, Huffman KE, et al. 2015. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet 47: 1475-1481
23. DeyS,SayersCM,Verginadis II,LehmanSL, ChengY,Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs SY, et al. 2015. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. J Clin Invest 125: 2592-2608
24. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, et al. 2013. Loss of FBP1 by Snailmediated repression provides metabolic advantages in basallike breast cancer. Cancer Cell 23: 316-331
25. Elchuri S, Oberley TD, QiW, Eisenstein RS, Jackson Roberts L, Van Remmen H, Epstein CJ, Huang TT. 2005. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 24: 367-380
26. Esteve JM, Armengod ME, Knecht E. 2010. BRCA1 negatively regulates formation of autophagic vacuoles in MCF-7 breast cancer cells. Exp Cell Res 316: 2618-2629
27. Fan J, Ye J, Kamphorst JJ, Shlomi T, Thompson CB, Rabinowitz JD. 2014. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510: 298-302
28. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. 2007. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121: 2381-2386
29. Feig DI, Reid TM, Loeb LA. 1994. Reactive oxygen species in tumorigenesis. Cancer Res 54: 1890s-1894s
30. Felsher DW, Bishop JM. 1999. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci 96: 3940-3944
31. Ferraro D, Corso S, Fasano E, Panieri E, Santangelo R, Borrello S, Giordano S, Pani G, Galeotti T. 2006. Pro-metastatic signaling by c-Met through RAC-1 and reactive oxygen species (ROS). Oncogene 25: 3689-3698
32. Finkel T, Holbrook NJ. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247
33. Floyd RA. 1990. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 11: 1447-1450
34. Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Sesso HD, Buring JE. 2009. Vitamins E and C in the prevention of prostate and total cancer in men: The Physicians' Health Study II randomized controlled trial. JAMA 301: 52-62
35. Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, Mac-Fadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE. 2012. Multivitamins in the prevention of cancer in men: The Physicians' Health Study II randomized controlled trial. JAMA 308: 1871-1880
36. Glasauer A, Sena LA, Diebold LP, Mazar AP, Chandel NS. 2014. Targeting SOD1 reduces experimental non-small-cell lung cancer. J Clin Invest 124: 117-128
37. Gorrini C, Baniasadi PS, Harris IS, Silvester J, Inoue S, Snow B, Joshi PA,Wakeham A, Molyneux SD, Martin B, et al. 2013a. BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. J Exp Med 210: 1529-1544
38. Gorrini C, Harris IS, Mak TW. 2013b. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12: 931-947
39. Granados-Principal S,Quiles JL, Ramirez-Tortosa CL, Sanchez-Rovira P, Ramirez-Tortosa MC. 2010. New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol 48: 1425-1438
40. Green DR, Chipuk JE. 2006. p53 and metabolism: Inside the TIGAR. Cell 126: 30-32
41. Greenwald P, Nixon DW, Malone WF, Kelloff GJ, Stern HR, Witkin KM. 1990. Concepts in cancer chemoprevention research. Cancer 65: 1483-1490
42. Hagenbuchner J, Kuznetsov AV, Obexer P, Ausserlechner MJ. 2013. BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. Oncogene 32: 4748-4757
43. Harman D. 1956. Aging: A theory based on free radical and radiation chemistry. J Gerontol 11: 298-300
44. Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA, et al. 2015. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27: 211-222
45. Hawkes HJ, Karlenius TC, Tonissen KF. 2014. Regulation of the human thioredoxin gene promoter and its key substrates: A study of functional and putative regulatory elements. Biochim Biophys Acta 1840: 303-314
46. Hayes JD, Dinkova-Kostova AT. 2014. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39: 199-218
47. Hayes JD, McMahon M. 2006. The double-edged sword of Nrf2: Subversion of redox homeostasis during the evolution of cancer. Mol Cell 21: 732-734
48. Hayes JD, McMahon M. 2009. NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer. Trends Biochem Sci 34: 176-188
49. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, et al. 1996. Lack of effect of long-term supplementation with b carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334: 1145-1149
50. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S. 2004. The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335-2342
51. Hercberg S, Ezzedine K, Guinot C, Preziosi P, Galan P, Bertrais S, Estaquio C, Briancon S, Favier A, Latreille J, et al. 2007. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 137: 2098-2105
52. Hernandez-Garcia D, Wood CD, Castro-Obregon S, Covarrubias L. 2010. Reactive oxygen species: A radical role in development? Free Radic Biol Med 49: 130-143
53. Higa A, Chevet E. 2012. Redox signaling loops in the unfolded protein response. Cell Signal 24: 1548-1555
54. Higgins LG, Kelleher MO, Eggleston IM, Itoh K, Yamamoto M, Hayes JD. 2009. Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol Appl Pharmacol 237: 267-280
55. Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. 2006. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett 243: 170-192
56. Hu T, Zhang C, Tang Q, Su Y, Li B, Chen L, Zhang Z, Cai T, Zhu Y. 2013. Variant G6PD levels promote tumor cell proliferation or apoptosis via the STAT3/5 pathway in the human melanoma xenograft mouse model. BMC Cancer 13: 251
57. Iida K, Itoh K, Kumagai Y, Oyasu R, Hattori K, Kawai K, Shimazui T, Akaza H, Yamamoto M. 2004. Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res 64: 6424-6431
58. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. 1997. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275: 1649-1652
59. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y, Hayashi J. 2008. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664
60. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, Nomiyama K, Hosokawa K, Sakurada K, Nakagata N, et al. 2004. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431: 997-1002
61. Jacobs C, Hutton B, Ng T, Shorr R, Clemons M. 2015. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review. Oncologist 20: 210-223
62. Jeon SM, Chandel NS, Hay N. 2012. AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485: 661-665
63. Jeong W, Bae SH, Toledano MB, Rhee SG. 2012. Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radic Biol Med 53: 447-456
64. Jezierska-Drutel A, Rosenzweig SA, Neumann CA. 2013. Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 119: 107-125
65. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. 2013. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 493: 689-693
66. Jose C, Bellance N, Rossignol R. 2011. Choosing between glycolysis and oxidative phosphorylation: A tumor's dilemma? Biochim Biophys Acta 1807: 552-561
67. Kamarajugadda S, Stemboroski L, Cai Q, Simpson NE, Nayak S, Tan M, Lu J. 2012. Glucose oxidation modulates anoikis and tumor metastasis. Mol Cell Biol 32: 1893-1907
68. Kamarajugadda S, Cai Q, Chen H, Nayak S, Zhu J, He M, Jin Y, Zhang Y, Ai L, Martin SS, et al. 2013. Manganese superoxide dismutase promotes anoikis resistance and tumor metastasis. Cell Death Dis 4: e 504
69. Karp DD, Lee SJ, Keller SM, Wright GS, Aisner S, Belinsky SA, Johnson DH, Johnston MR, Goodman G, Clamon G, et al. 2013. Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. J Clin Oncol 31: 4179-4187
70. Kaur A, Webster MR, Marchbank K, Behera R, Ndoye A, Kugel CH III, Dang VM, Appleton J, O'Connell MP, Cheng P, et al. 2016. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance. Nature 532: 250-254
71. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J,Winkler F. 2010. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16: 116-122
72. Kim SH, Kim MO, Gao P, Youm CA, Park HR, Lee TS, Kim KS, Suh JG, Lee HT, Park BJ, et al. 2005. Overexpression of extracellular superoxide dismutase (EC-SOD) in mouse skin plays a protective role in DMBA/TPA-induced tumor formation. Oncol Res 15: 333-341
73. Klein EA, Thompson IM Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, et al. 2011. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306: 1549-1556
74. Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, et al. 2014. Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. J Natl Cancer Inst 106: djt 456
75. Kuehne A, Emmert H, Soehle J,Winnefeld M, Fischer F,Wenck H, Gallinat S, Terstegen L, Lucius R, Hildebrand J, et al. 2015. Acute activation of oxidative pentose phosphate pathway as first-line response to oxidative stress in human skin cells. Mol Cell 59: 359-371
76. Lander HM, Hajjar DP, Hempstead BL, Mirza UA, Chait BT, Campbell S, Quilliam LA. 1997. A molecular redox switch on p21ras. Structural basis for the nitric oxide-p21ras interaction. J Biol Chem 272: 4323-4326
77. LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis MC, de Carvalho FM, Damascena A, Domingos Chinen LT, Rocha RM, et al. 2014. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol 16: 992-1003, 1001-1015
78. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH. 1999. b-Carotene supplementation and incidence of cancer and cardiovascular disease: TheWomen's Health Study. J Natl Cancer Inst 91: 2102-2106
79. Lee SR, Yang KS, Kwon J, Lee C, Jeong W, Rhee SG. 2002. Reversible inactivation of the tumor suppressor PTEN by H2O2. J Biol Chem 277: 20336-20342
80. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. 2003. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 278: 12029-12038
81. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE. 2005. Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial. JAMA 294: 56-65
82. Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, Dalin MG, Akyurek LM, Lindahl P, Nilsson J, et al. 2015. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med 7: 308re 308
83. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP. 2003. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22: 5501-5510
84. Lewerenz J, Hewett SJ, Huang Y, Lambros M, GoutPW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, et al. 2013. The cystine/glutamate antiporter system xc 2 in health and disease: From molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18: 522-555
85. Lewis CA, Parker SJ, Fiske BP, McCloskey D, Gui DY, Green CR, Vokes NI, Feist AM, Vander Heiden MG, Metallo CM. 2014. Tracing compartmentalized NADPH metabolism in the cytosol and mitochondria of mammalian cells. Mol Cell 55: 253-263
86. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, et al. 2009. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301: 39-51
87. Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK, Multani A, Chang S, Lozano G. 2004. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 36: 63-68
88. Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharfi H, et al. 2011. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 43: 869-874
89. Lu J, Holmgren A. 2014. The thioredoxin antioxidant system. Free Radic Biol Med 66: 75-87
90. Lu X, Bennet B, Mu E, Rabinowitz J, Kang Y. 2010. Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. J Biol Chem 285: 9317-9321
91. Luo C, Lim JH, Lee Y, Granter SR, Thomas A, Vazquez F, Widlund HR, Puigserver P. 2016. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis. Nature 537: 422-426
92. Luzzi KJ, MacDonald IC, Schmidt EE, Kerkvliet N, Morris VL, Chambers AF, Groom AC. 1998. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153: 865-873
93. Lyu YL, Kerrigan JE, Lin CP, Azarova AM, Tsai YC, Ban Y, Liu LF. 2007. Topoisomerase IIb mediated DNA doublestrand breaks: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Cancer Res 67: 8839-8846
94. Ma Q. 2013. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53: 401-426
95. Malhotra JD, Miao H, Zhang K, Wolfson A, Pennathur S, Pipe SW, Kaufman RJ. 2008. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc Natl Acad Sci 105: 18525-18530
96. Martinez-Cayuela M. 1995. Oxygen free radicals and human disease. Biochimie 77: 147-161
97. Meyer F, Bairati I, Fortin A, Gelinas M, Nabid A, Brochet F, Tetu B. 2008. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: A randomized trial among head and neck cancer patients. Int J Cancer 122: 1679-1683
98. Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, Motohashi H. 2012. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22: 66-79
99. Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, Basso G, Leo G, Rosato A, Bicciato S, et al. 2012. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature 487: 380-384
100. Moon EJ, Giaccia A. 2015. Dual roles of NRF2 in tumor prevention and progression: Possible implications in cancer treatment. Free Radic Biol Med 79: 292-299
101. Moyer VA; U.S. Preventive Services Task Force. 2014. Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160: 558-564
102. Mullarky E, Mattaini KR, Vander Heiden MG, Cantley LC, Locasale JW. 2011. PHGDH amplification and altered glucose metabolism in human melanoma. Pigment Cell Melanoma Res 24: 1112-1115
103. Myung SK, Kim Y, Ju W, Choi HJ, Bae WK. 2010. Effects of antioxidant supplements on cancer prevention: Meta-analysis of randomized controlled trials. Ann Oncol 21: 166-179
104. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, et al. 2007. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239
105. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH, Van Etten RA. 2003. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565
106. Nguyen A, Loo JM, Mital R, Weinberg EM, Man FY, Zeng Z, Paty PB, Saltz L, Janjigian YY, de Stanchina E, et al. 2016. PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis. J Clin Invest 126: 681-694
107. Nioi P, Hayes JD. 2004. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat Res 555: 149-171
108. Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes JD. 2003. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: Reassessment of the ARE consensus sequence. Biochem J 374: 337-348
109. Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E, Nieborowska-Skorska M, Blasiak J, Skorski T. 2004. BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks. Blood 104: 3746-3753
110. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, et al. 2008. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 68: 1303-1309
111. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP,Meyskens FL Jr, Valanis B,Williams JH Jr, et al. 1996a. Risk factors for lung cancer and for intervention effects in CARET, the b-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88: 1550-1559
112. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, et al. 1996b. Effects of a combination of b carotene and vitaminA on lung cancer and cardiovascular disease. N Engl J Med 334: 1150-1155
113. Patra KC, Hay N. 2014. The pentose phosphate pathway and cancer. Trends Biochem Sci 39: 347-354
114. Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, Leitch AM, Johnson TM, DeBerardinis RJ, Morrison SJ. 2015. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527: 186-191
115. Porporato PE, Payen VL, Perez-Escuredo J, De Saedeleer CJ, Danhier P, Copetti T, Dhup S, Tardy M, Vazeille T, Bouzin C, et al. 2014. A mitochondrial switch promotes tumor metastasis. Cell Rep 8: 754-766
116. Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S,Woo HK, Jang HG, Jha AK, et al. 2011. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476: 346-350
117. Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD, Johnson LL, Gail MH, Dong ZW, Yu B, et al. 2009. Total and cancer mortality after supplementation with vitamins and minerals: Follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst 101: 507-518
118. Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, Bukoye BA, Liu B, Lee AV, Lin X, et al. 2011. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-kB signaling. J Clin Invest 121: 212-225
119. Raj L, Ide T, Gurkar AU, Foley M, Schenone M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, et al. 2011. Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 475: 231-234
120. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. 2001. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci 98: 3410-3415
121. Ranjan P, Anathy V, Burch PM, Weirather K, Lambeth JD, Heintz NH. 2006. Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cells. Antioxid Redox Signal 8: 1447-1459
122. Reliene R, Schiestl RH. 2006. Antioxidant N-acetyl cysteine reduces incidence and multiplicity of lymphoma in Atm deficient mice. DNA Repair (Amst) 5: 852-859
123. Reliene R, Fischer E, Schiestl RH. 2004. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in Atm-deficient mice. Cancer Res 64: 5148-5153
124. Ren JG, Seth P, Clish CB, Lorkiewicz PK, Higashi RM, Lane AN, Fan TW, Sukhatme VP. 2014. Knockdown of malic enzyme 2 suppresses lung tumor growth, induces differentiation and impacts PI3K/AKT signaling. Sci Rep 4: 5414
125. Reznik E, Miller ML, Senbabaoglu Y, Riaz N, Sarungbam J, Tickoo SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, et al. 2016. Mitochondrial DNA copy number variation across human cancers. Elife 5: e 10769
126. Rhee SG. 2006. Cell signaling. H2O2, a necessary evil for cell signaling. Science 312: 1882-1883
127. Rolfs F, Huber M, Gruber F, Bohm F, Pfister HJ, Bochkov VN, Tschachler E, Dummer R, Hohl D, Schafer M, et al. 2013. Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis. Cancer Res 73: 3460-3469
128. Rowe LA, Degtyareva N, Doetsch PW. 2008. DNA damageinduced reactive oxygen species (ROS) stress response in Saccharomyces cerevisiae. Free Radic Biol Med 45: 1167-1177
129. Rushmore TH, Morton MR, Pickett CB. 1991. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem 266: 11632-11639
130. Sabharwal SS, Schumacker PT. 2014. Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles' heel? Nat Rev Cancer 14: 709-721
131. Sablina AA, Budanov AV, Ilyinskaya GV, Agapova LS, Kravchenko JE, Chumakov PM. 2005. The antioxidant function of the p53 tumor suppressor. Nat Med 11: 1306-1313
132. Santos MA, Faryabi RB, Ergen AV, Day AM, Malhowski A, CanelaA, OnozawaM, Lee JE, Callen E,Gutierrez-Martinez P, et al. 2014. DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier. Nature 514: 107-111
133. Satoh H, Moriguchi T, Taguchi K, Takai J, Maher JM, Suzuki T, Winnard PT Jr, Raman V, Ebina M, Nukiwa T, et al. 2010. Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. Carcinogenesis 31: 1833-1843
134. Satoh H, Moriguchi T, Takai J, Ebina M, Yamamoto M. 2013. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis. Cancer Res 73: 4158-4168
135. Sattler M, Verma S, Shrikhande G, Byrne CH, Pride YB, Winkler T, Greenfield EA, Salgia R, Griffin JD. 2000. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 275: 24273-24278
136. Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, Bergo MO. 2014. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 6: 221ra 215
137. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, Gao S, Puigserver P, Brugge JS. 2009. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461: 109-113
138. Schieber M, Chandel NS. 2014. ROS function in redox signaling and oxidative stress. Curr Biol 24: R453-R 462
139. Schrader M, Fahimi HD. 2006. Peroxisomes and oxidative stress. Biochim Biophys Acta 1763: 1755-1766
140. Semenza GL. 2011. Regulation of metabolism by hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol 76: 347-353
141. Senft D, Ronai ZA. 2016. Regulators of mitochondrial dynamics in cancer. Curr Opin Cell Biol 39: 43-52
142. Shi Z, Wang B, Chihanga T, Kennedy MA, Weber GF. 2014. Energy metabolism during anchorage-independence. Induction by osteopontin-c. PLoS ONE 9: e 105675
143. Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T,Yamamoto M, Hirohashi S. 2008a. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135: 1358-1368, 1368 e1351-1354
144. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, Hirohashi S. 2008b. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci 105: 13568-13573
145. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, Herman JG, Baylin SB, Sidransky D, Gabrielson E, et al. 2006. Dysfunctional KEAP1-NRF2 interaction in non-smallcell lung cancer. PLoS Med 3: e 420
146. Singh A, Happel C, Manna SK, Acquaah-Mensah G, Carrerero J, Kumar S, Nasipuri P, KrauszKW,Wakabayashi N, Dewi R, et al. 2013. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest 123: 2921-2934
147. Son J, Lyssiotis CA, Ying H,Wang X, Hua S, Ligorio M, Perera RM, Ferrone CR, Mullarky E, Shyh-Chang N, et al. 2013. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496: 101-105
148. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, Ulkus L, Inserra EJ, Ulman M, Springer S, Nakamura Z, et al. 2010. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med 2: 25ra 23
149. Sukhatme VP, Chan B. 2012. Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. FEBS Lett 586: 2389-2395
150. Sullivan JP, Nahed BV, Madden MW, Oliveira SM, Springer S, Bhere D, Chi AS, Wakimoto H, Rothenberg SM, Sequist LV, et al. 2014. Brain tumor cells in circulation are enriched for mesenchymal gene expression. Cancer Discov 4: 1299-1309
151. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. 1995. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299
152. Szatrowski TP, Nathan CF. 1991. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798
153. Tasdogan A, Kumar S, Allies G, Bausinger J, Beckel F, Hofemeister H, Mulaw M, Madan V, Scharfetter-Kochanek K, Feuring-Buske M, et al. 2016. DNA damage-induced HSPC malfunction depends on ROS accumulation downstream of IFN-1 signaling and bid mobilization. Cell Stem Cell 19: 752-767
154. Thimmulappa RK, Mai KH, Srisuma S, KenslerTW, Yamamoto M, Biswal S. 2002. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62: 5196-5203
155. Toullec A, Gerald D, Despouy G, Bourachot B, Cardon M, Lefort S, Richardson M, Rigaill G, Parrini MC, Lucchesi C, et al. 2010. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med 2: 211-230
156. Vafa O,Wade M, Kern S, Beeche M, Pandita TK, Hampton GM, Wahl GM. 2002. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability. Mol Cell 9: 1031-1044
157. Vanharanta S, Massague J. 2013. Origins of metastatic traits. Cancer Cell 24: 410-421
158. Vanharanta S, ShuW, Brenet F, Hakimi AA, Heguy A, Viale A, Reuter VE, Hsieh JJ, Scandura JM, Massague J. 2013. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat Med 19: 50-56
159. Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson NL, Baynes JW, Epstein CJ, Huang TT, et al. 2003. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 16: 29-37
160. van Zandwijk N, Dalesio O, Pastorino U, de Vries N, van Tinteren H. 2000. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the European Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. J Natl Cancer Inst 92: 977-986
161. Vera-Ramirez L, Ramirez-Tortosa M, Perez-Lopez P, Granados-Principal S, Battino M, Quiles JL. 2012. Long-term effects of systemic cancer treatment on DNA oxidative damage: The potential for targeted therapies. Cancer Lett 327: 134-141
162. Vyas S, Zaganjor E, Haigis MC. 2016. Mitochondria and cancer. Cell 166: 555-566
163. Wang H, Liu X, Long M, Huang Y, Zhang L, Zhang R, Zheng Y, Liao X, Wang Y, Liao Q, et al. 2016. NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis. Sci Transl Med 8: 334ra 351
164. Wu KC, Cui JY, Klaassen CD. 2011. Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol Sci 123: 590-600
165. Xu C, Huang MT, Shen G, Yuan X, Lin W, Khor TO, Conney AH, Kong AN. 2006. Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res 66: 8293-8296
166. Yasueda A, Urushima H, Ito T. 2016. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: A systematic review. Integr Cancer Ther 15: 17-39
167. Ye J, Fan J, Venneti S,Wan YW, Pawel BR, Zhang J, Finley LW, Lu C, Lindsten T, Cross JR, et al. 2014. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov 4: 1406-1417
168. Yu M, Bardia A,Wittner BS, Stott SL, Smas ME, Ting DT, Isakoff SJ, Ciciliano JC,Wells MN, Shah AM, et al. 2013. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339: 580-584
169. Yu M, Bardia A, Aceto N, Bersani F, Madden MW, Donaldson MC, Desai R, Zhu H, Comaills V, Zheng Z, et al. 2014. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345: 216-220
170. Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, Yeh ET. 2012. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18: 1639-1642
171. Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, Abel PW, Tu Y. 2013. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32: 4814-4824
172. Zhao T, Zhu Y, Morinibu A, Kobayashi M, Shinomiya K, Itasaka S, Yoshimura M, Guo G, Hiraoka M, Harada H. 2014. HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs. Sci Rep 4: 3793